New Low-Cost radiation therapy could make liver cancer treatment accessible for all

NCT ID NCT07436988

Not yet recruiting Disease control Sponsor: Post Graduate Institute of Medical Education and Research, Chandigarh Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a new, affordable type of radioactive microsphere for treating liver cancer that cannot be removed by surgery. The microspheres are delivered directly to the tumor through a blood vessel, delivering radiation to kill cancer cells. The trial will enroll 18 adults with advanced liver cancer to check for safety and side effects.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: radioactive microspheres (labeled with rhenium-188 or lutetium-177)
What this could lead to: If successful, this could provide a safe, effective, and low-cost treatment option for liver cancer patients who cannot have surgery.
What could go wrong: This is a very early Phase 1 safety trial with only 18 participants, so it is too soon to know if the treatment works or is safe long-term.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEPATECELLULAR CARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

hepatocellular carcinoma Liver Neoplasms

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEPATECELLULAR CARCINOMA

Contacts and locations

Locations

All India Institute of Medical Sciences

Bhubaneswar, Odisha, 751019, India
All India Institute of Medical Sciences

Delhi, South Delhi, 110029, India
Jawaharlal Institute of Postgraduate Medical Education and Research

Puducherry, Puducherry, 605006, India
Postgraduate Institute of Medical Education and Research

Chandigarh, Chandigarh, 160012, India
Tata Memorial Hospital

Mumbai, Maharashtra, 400012, India

More trials for these conditions

Other studies related to the condition(s) this trial covers.